Life Sciences Group Of The Year: Paul Hastings
Paul Hastings LLP's precedent setting victory for Sunovion Pharmaceuticals Inc. and its representation of Avalon Ventures in the formation of a $495 million venture fund, among other key wins and high-end...To view the full article, register now.
Already a subscriber? Click here to view full article